Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Beck

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Peptides|September 10, 2005
Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alphaPersefoni Klimentzou, Maria Paravatou-Petsotas, Christos Zikos, et al.
The Journal of Biological Chemistry|September 1, 2005
The phosphorylation of Ser318 of insulin receptor substrate 1 is not per se inhibitory in skeletal muscle cells but is necessary to trigger the attenuation of the insulin-stimulated signalCora Weigert, Anita M Hennige, Tasja Brischmann, et al.
Clinical Epigenetics|March 7, 2018
Overexpression of <i>UHRF1</i> promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastomaAlexander Beck, Franziska Trippel, Alexandra Wagner, et al.
Biological Chemistry|November 4, 2006
Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chainThomas Rückrich, Jens Brandenburg, Alexander Cansier, et al.
Journal of Hepatology|August 20, 2014
The genomic landscape of hepatoblastoma and their progenies with HCC-like featuresMelanie Eichenmüller, Franziska Trippel, Michaela Kreuder, et al.
Cancer Immunology, Immunotherapy : CII|February 3, 2006
The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patientsMargarita Skopeliti, Ioannis F Voutsas, Persefoni Klimentzou, et al.
Annals of Nuclear Medicine|August 7, 2012
Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasiaVera Froeling, Florian Elgeti, Martin H Maurer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cellsTimo Burster, Alexander Beck, Eva Tolosa, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel techniqueJens Ricke, Peter Wust, Anna Stohlmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2004
[CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases]Jens Ricke, Peter Wust, Anna Stohlmann, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Peptides|September 10, 2005
Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alphaPersefoni Klimentzou, Maria Paravatou-Petsotas, Christos Zikos, et al.
The Journal of Biological Chemistry|September 1, 2005
The phosphorylation of Ser318 of insulin receptor substrate 1 is not per se inhibitory in skeletal muscle cells but is necessary to trigger the attenuation of the insulin-stimulated signalCora Weigert, Anita M Hennige, Tasja Brischmann, et al.
Clinical Epigenetics|March 7, 2018
Overexpression of <i>UHRF1</i> promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastomaAlexander Beck, Franziska Trippel, Alexandra Wagner, et al.
Biological Chemistry|November 4, 2006
Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chainThomas Rückrich, Jens Brandenburg, Alexander Cansier, et al.
Journal of Hepatology|August 20, 2014
The genomic landscape of hepatoblastoma and their progenies with HCC-like featuresMelanie Eichenmüller, Franziska Trippel, Michaela Kreuder, et al.
Cancer Immunology, Immunotherapy : CII|February 3, 2006
The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patientsMargarita Skopeliti, Ioannis F Voutsas, Persefoni Klimentzou, et al.
Annals of Nuclear Medicine|August 7, 2012
Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasiaVera Froeling, Florian Elgeti, Martin H Maurer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cellsTimo Burster, Alexander Beck, Eva Tolosa, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel techniqueJens Ricke, Peter Wust, Anna Stohlmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2004
[CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases]Jens Ricke, Peter Wust, Anna Stohlmann, et al.
Pageof 10